Literature DB >> 20605167

Effects of nuclear factor-κB inhibitors on colon anastomotic healing in rats.

Abdulkadir Bedirli1, Bulent Salman, Hatice Pasaoglu, Ebru Ofluoglu, Omer Sakrak.   

Abstract

BACKGROUND: Nuclear factor (NF)-κB plays an essential role in inflammation. We tested this role by administering NF-κB-inhibitors into rats undergoing a well-established model of colonic anastomotic healing.
METHODS: Wistar rats underwent laparotomy, descending colonic transection, and handsewn reanastomosis. The animals were randomized to receive either a selective NF-κB inhibitor (parthenolide 0.5 mg/kg or resveratrol 0.5 mg/kg) or an equal volume of water by gavages before operation and then daily after surgery. Animals were sacrificed either immediately after anastomotic construction (d 0) or at the third, fifth, or seventh postoperative day.
RESULTS: Both parthenolide and resveratrol treatment led to early significant increases in plasma levels of IL-6. On d 7, hydroxyproline levels were significantly higher in the parthenolide and resveratrol groups. A similar pattern was observed with the bursting pressure. In contrast, gelatinase activity (MMP-2 and MMP-9 expression) was significantly higher in the control group on postoperative d 3. On d 3, expression of NF-κB activity was up-regulated in the anastomotic area. Both parthenolide and resveratrol completely attenuated NF-κB activity. Study groups also developed more marked inflammatory cell infiltration and collagen deposition on histology analysis.
CONCLUSIONS: Parthenolide and resveratrol significantly improved healing and mechanical stability of colonic anastomoses in rats during the early postoperative period. Both agents may be acting to accelerate the host reparative process as well as to enhance protection of the anastomotic wound bed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605167     DOI: 10.1016/j.jss.2010.01.028

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-23

Review 2.  Pharmacological interventions for improved colonic anastomotic healing: a meta-analysis.

Authors:  Mari Nanna Oines; Peter-Martin Krarup; Lars Nannestad Jorgensen; Magnus Sven Agren
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Exogenous recombinant adiponectin improves survival in experimental abdominal sepsis.

Authors:  Bülent Salman; Tonguç Utku Yılmaz; Tugan Tezcaner; Ebru Ofluoğlu Demir; Ozge Tuğçe Paşaoğlu
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

4.  Effects of resveratrol on incisional wound healing in rats.

Authors:  Ismail Yaman; Hayrullah Derici; Cemal Kara; Erdinc Kamer; Gulden Diniz; Ragip Ortac; Oya Sayin
Journal:  Surg Today       Date:  2012-12-15       Impact factor: 2.549

5.  Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Alexander G Weil; Richard Béliveau
Journal:  Onco Targets Ther       Date:  2010-11-15       Impact factor: 4.147

6.  Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation.

Authors:  Juan Li; Wei Zhong; Weiwei Wang; Shaoping Hu; Jiahui Yuan; Bing Zhang; Tianhui Hu; Gang Song
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

7.  The time course of cytokine expressions plays a determining role in faster healing of intestinal and colonic anastomatic wounds.

Authors:  Ahmad M Zubaidi; Tajamul Hussain; Mohammed A Alzoghaibi
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.